Skip to Main Content

Paper Details

Resistance Mechanisms to Anti-Epidermal Growth Factor Receptor Therapy in <i>RAS/RAF</i> Wild-Type Colorectal Cancer Vary by Regimen and Line of Therapy.
J Clin Oncol
19
2023
Author NameAffiliation
John Paul ShenThe University of Texas MD Anderson Cancer Center
Eduardo VilarThe University of Texas MD Anderson Cancer Center
Eduardo VilarThe University of Texas MD Anderson Cancer Center
Scott KopetzThe University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2